WO2005113598A3 - Membres de la superfamille des tnf avec immunogenicite modifiee - Google Patents
Membres de la superfamille des tnf avec immunogenicite modifiee Download PDFInfo
- Publication number
- WO2005113598A3 WO2005113598A3 PCT/US2005/018130 US2005018130W WO2005113598A3 WO 2005113598 A3 WO2005113598 A3 WO 2005113598A3 US 2005018130 W US2005018130 W US 2005018130W WO 2005113598 A3 WO2005113598 A3 WO 2005113598A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- super family
- family members
- altered immunogenicity
- tnf super
- relates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70575—NGF/TNF-superfamily, e.g. CD70, CD95L, CD153, CD154
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Applications Claiming Priority (12)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US57339504P | 2004-05-21 | 2004-05-21 | |
US57320604P | 2004-05-21 | 2004-05-21 | |
US57330104P | 2004-05-21 | 2004-05-21 | |
US60/573,301 | 2004-05-21 | ||
US60/573,395 | 2004-05-21 | ||
US60/573,206 | 2004-05-21 | ||
US58831404P | 2004-07-14 | 2004-07-14 | |
US60/588,314 | 2004-07-14 | ||
US60739704P | 2004-09-02 | 2004-09-02 | |
US60739604P | 2004-09-02 | 2004-09-02 | |
US60/607,397 | 2004-09-02 | ||
US60/607,396 | 2004-09-02 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005113598A2 WO2005113598A2 (fr) | 2005-12-01 |
WO2005113598A3 true WO2005113598A3 (fr) | 2006-06-01 |
Family
ID=35428917
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2005/018130 WO2005113598A2 (fr) | 2004-05-21 | 2005-05-23 | Membres de la superfamille des tnf avec immunogenicite modifiee |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2005113598A2 (fr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2626082C (fr) | 2005-10-13 | 2017-04-11 | Human Genome Sciences, Inc. | Procedes et compositions destinees au traitement de patients atteints de maladies positives pour des auto-anticorps |
ES2520026T3 (es) | 2006-09-18 | 2014-11-11 | The Board Of Trustees Of The University Of Arkansas | Composiciones y métodos para potenciar respuestas inmunitarias |
BRPI0818736A2 (pt) | 2007-10-30 | 2017-06-13 | Univ Arkansas | composições e métodos para intensificar imunorrepostas à bactéria flagelada |
ES2599905T3 (es) | 2007-11-01 | 2017-02-06 | The Board Of Trustees Of The University Of Arkansas | Composiciones y métodos para aumentar las respuestas inmunitarias a Eimeria |
NO2525817T3 (fr) | 2010-01-21 | 2018-01-06 | ||
PT2579901T (pt) | 2010-06-09 | 2019-11-05 | Univ Arkansas | Vacina e métodos para reduzir infeção por campylobacter |
EP2956165B1 (fr) | 2013-02-14 | 2019-09-11 | The Board of Trustees of the University of Arkansas | Compositions et procédés pour renforcer des réponses immunitaires vis-à-vis d'eimeria ou limiter une infection par eimeria |
EP3578190A1 (fr) | 2013-03-15 | 2019-12-11 | The Board of Trustees of the University of Arkansas | Compositions et procédés pour améliorer les réactions immunitaires aux pathogènes entériques |
MX2018013331A (es) | 2016-05-03 | 2019-06-10 | Univ Arkansas | Vector de vacuna de levadura que incluye polipeptidos inmunoestimuladores y antigenicos y metodos para su uso. |
AU2021412369A1 (en) * | 2020-12-29 | 2023-07-13 | Cemm - Forschungszentrum Für Molekulare Medizin Gmbh | Anti-april antibodies and uses thereof |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999012965A2 (fr) * | 1997-09-12 | 1999-03-18 | Biogen, Inc. | Nouveaux ligands de la famille des tnf |
WO2000067034A1 (fr) * | 1999-04-30 | 2000-11-09 | Immunex Corporation | Methodes d'utilisation de l'interaction taci/taci-l |
WO2002018445A2 (fr) * | 2000-09-01 | 2002-03-07 | Biogen, Inc. | Structure co-cristalline de l'anticorps monoclonal 5c8 et cd154, et utilisation de cette structure dans la mise au point de medicaments |
WO2002036141A2 (fr) * | 2000-11-02 | 2002-05-10 | Immunex Corporation | Methode permettant d'ameliorer des reponses immunitaires induites par des lymphocytes |
US20020061525A1 (en) * | 2000-05-16 | 2002-05-23 | Rodrigo Yelin | Sequences of trail variants |
WO2003006154A2 (fr) * | 2001-07-10 | 2003-01-23 | Xencor, Inc. | Automatisation de conception de proteines pour la conception de bibliotheques de proteines a antigenicite modifiee |
WO2003029420A2 (fr) * | 2001-10-02 | 2003-04-10 | Genentech, Inc. | Variants de ligands apo-2 et leurs utilisations |
WO2003059281A2 (fr) * | 2002-01-04 | 2003-07-24 | Xencor | Nouveaux variants de proteines rankl |
WO2004081043A2 (fr) * | 2003-01-06 | 2004-09-23 | Xencor, Inc. | Variants de baff et leurs methodes d'utilisation |
WO2004089982A2 (fr) * | 2003-01-06 | 2004-10-21 | Xencor | Variantes april et leurs procedes |
WO2005035570A2 (fr) * | 2003-10-10 | 2005-04-21 | Xencor, Inc. | Nouveaux variants de la proteine cd40l |
-
2005
- 2005-05-23 WO PCT/US2005/018130 patent/WO2005113598A2/fr active Application Filing
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999012965A2 (fr) * | 1997-09-12 | 1999-03-18 | Biogen, Inc. | Nouveaux ligands de la famille des tnf |
WO2000067034A1 (fr) * | 1999-04-30 | 2000-11-09 | Immunex Corporation | Methodes d'utilisation de l'interaction taci/taci-l |
US20020061525A1 (en) * | 2000-05-16 | 2002-05-23 | Rodrigo Yelin | Sequences of trail variants |
WO2002018445A2 (fr) * | 2000-09-01 | 2002-03-07 | Biogen, Inc. | Structure co-cristalline de l'anticorps monoclonal 5c8 et cd154, et utilisation de cette structure dans la mise au point de medicaments |
WO2002036141A2 (fr) * | 2000-11-02 | 2002-05-10 | Immunex Corporation | Methode permettant d'ameliorer des reponses immunitaires induites par des lymphocytes |
WO2003006154A2 (fr) * | 2001-07-10 | 2003-01-23 | Xencor, Inc. | Automatisation de conception de proteines pour la conception de bibliotheques de proteines a antigenicite modifiee |
WO2003029420A2 (fr) * | 2001-10-02 | 2003-04-10 | Genentech, Inc. | Variants de ligands apo-2 et leurs utilisations |
WO2003059281A2 (fr) * | 2002-01-04 | 2003-07-24 | Xencor | Nouveaux variants de proteines rankl |
WO2004081043A2 (fr) * | 2003-01-06 | 2004-09-23 | Xencor, Inc. | Variants de baff et leurs methodes d'utilisation |
WO2004089982A2 (fr) * | 2003-01-06 | 2004-10-21 | Xencor | Variantes april et leurs procedes |
WO2005035570A2 (fr) * | 2003-10-10 | 2005-04-21 | Xencor, Inc. | Nouveaux variants de la proteine cd40l |
Also Published As
Publication number | Publication date |
---|---|
WO2005113598A2 (fr) | 2005-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005113598A3 (fr) | Membres de la superfamille des tnf avec immunogenicite modifiee | |
WO2006105338A3 (fr) | Variants fc presentant des proprietes optimisees | |
WO2004075861A3 (fr) | Production de virus recombines adeno associes | |
WO2006010057A3 (fr) | Peptides therapeutiques | |
WO2007041635A3 (fr) | Variants de fc dotés de propriétés de liaison aux récepteurs fc optimisées | |
WO2006076594A3 (fr) | Anticorps et proteines de fusion fc a immunogenicite modifiee | |
WO2004099249A3 (fr) | Variants fc optimises et leurs procedes de generation | |
WO2006009888A3 (fr) | Proteines de liaison de kinase c-met | |
WO2008140493A3 (fr) | Anticorps de la famille anti-egfr, anticorps de la famille anti-egfr bispécifiques et leurs procédés d'utilisation | |
WO2006037810A3 (fr) | Composes de glp-1 a action prolongee | |
EP1824971A4 (fr) | Genes clostridiaux genetiquement modifies, proteines codees par ces genes modifies et utilisations de ceux-ci | |
WO2006070023A3 (fr) | Methode d'annulation de la multiresistance dans des cellules animales | |
WO2007112279A3 (fr) | Résonateurs | |
WO2004031352A3 (fr) | Variants d'interferons presentant des proprietes ameliorees | |
Vehmasvaara | Ensihoitotyön fyysinen kuormittavuus ja ensihoitajien työkyvyn fyysisiä edellytyksiä arvioivan testistön kehittäminen | |
WO2008005487A3 (fr) | Séquences peptidiques permettant la modulation de la protéine kinase c | |
ZA200502539B (en) | Side-discharge grape harvester. | |
WO2006013462A3 (fr) | Facteurs de croissance nsg28, nsg30, et nsg32 | |
WO2003059281A3 (fr) | Nouveaux variants de proteines rankl | |
Kattainen | Pitkittäistutkimus sepelvaltimoiden ohitusleikkaus-ja pallolaajennuspotilaiden terveyteen liittyvästä elämänlaadusta | |
EP1724341A4 (fr) | Peptide nas novateur modifiant la sensation de goût, adn de celui-ci et son utilisation | |
WO2005077353A8 (fr) | Dichloroacetate associe a un inotrope dans la cardioprotection | |
Corliss | The Best Movies of 2004 | |
Anishchik et al. | Gradient Ti-Cr-N coatings: structure and mechanical properties; Gradientnye pokrytiya Ti-Cr-N: struktura i mekhanicheskie svojstva | |
Barood | Jerusalem: Settlements and Judization |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
122 | Ep: pct application non-entry in european phase |